Trial Information

Summary: Malignant Glioma (Cancerous tumor in the brain) - Adults

You may be eligible to participate in this study if you:

• Are 18 years of age or older
• Have been diagnosed with malignant glioma

You may not participate in this study if you:

• Have had chemotherapy, radiotherapy, immunotherapy, or investigational agents within 4 weeks
• Have any acute viral, bacterial, or fungal infection that requires systemic therapy within 14 days
• Have a hypersensitivity to paclitaxel
• Have had a severe toxic reaction to previous taxane treatment
• Have had treatment with P450 CYP 3A4 or CYP 2C8 enzyme-inducing anti-convulsant drugs, including but not limited to phenytoin, phenobarbitol, carbamazepine, fosphenytoin, primidone and oxcarbazepine within 14 days
• Have known or suspected, acute or chronic, active Hepatitis B or Hepatitis C or HIV/AIDS
• Have a respiratory, cardiac, liver or kidney disease or any other organ system dysfunction
• Are pregnant, breastfeeding, or intend to become pregnant during the study
• Have participated in another research study within the last 30 days

If you would like to learn more about participating in this study, please send an e-mail message using the form below.